Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models

Shaili Sharma, Aeju Lee, Kuiwon Choi, Kwangmeyung Kim, Inchan Youn, Stephen Trippel, Alyssa Panitch

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aggrecan, a major macromolecule in cartilage, protects the extracellular matrix (ECM) from degradation during the progression of osteoarthritis (OA). However, aggrecan itself is also susceptible to proteolytic cleavage. Here, the use of a biomimetic proteoglycan (mAGC) is presented, which functionally mimics aggrecan but lacks the known cleavage sites, protecting the molecule from proteolytic degradation. The objective of this study is to test the efficacy of this molecule in ex vivo (human OA synovial fluid) and in vivo (Sprague-Dawley rats) osteoarthritic models. These results indicate that mAGC's may protect articular cartilage against the loss of key ECM components, and lower catabolic protein and gene expression in both models. This suppression of matrix degradation has the potential to provide a healthy environment for tissue repair.

Original languageEnglish
Pages (from-to)1228-1237
Number of pages10
JournalMacromolecular Bioscience
Volume13
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Aggrecans
Biomimetics
Cartilage
Extracellular Matrix
Degradation
Osteoarthritis
Molecules
Synovial Fluid
Articular Cartilage
Proteoglycans
Macromolecules
Gene expression
Sprague Dawley Rats
Rats
Repair
Tissue
Proteins
Gene Expression
Fluids

Keywords

  • Aggrecan
  • Biomimetics
  • Cartilage
  • Extracellular matrix
  • Proteolytic enzymes

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

Cite this

Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models. / Sharma, Shaili; Lee, Aeju; Choi, Kuiwon; Kim, Kwangmeyung; Youn, Inchan; Trippel, Stephen; Panitch, Alyssa.

In: Macromolecular Bioscience, Vol. 13, No. 9, 09.2013, p. 1228-1237.

Research output: Contribution to journalArticle

Sharma, Shaili ; Lee, Aeju ; Choi, Kuiwon ; Kim, Kwangmeyung ; Youn, Inchan ; Trippel, Stephen ; Panitch, Alyssa. / Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models. In: Macromolecular Bioscience. 2013 ; Vol. 13, No. 9. pp. 1228-1237.
@article{a5dbb139bc914b1d8bd1546bda9d852c,
title = "Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models",
abstract = "Aggrecan, a major macromolecule in cartilage, protects the extracellular matrix (ECM) from degradation during the progression of osteoarthritis (OA). However, aggrecan itself is also susceptible to proteolytic cleavage. Here, the use of a biomimetic proteoglycan (mAGC) is presented, which functionally mimics aggrecan but lacks the known cleavage sites, protecting the molecule from proteolytic degradation. The objective of this study is to test the efficacy of this molecule in ex vivo (human OA synovial fluid) and in vivo (Sprague-Dawley rats) osteoarthritic models. These results indicate that mAGC's may protect articular cartilage against the loss of key ECM components, and lower catabolic protein and gene expression in both models. This suppression of matrix degradation has the potential to provide a healthy environment for tissue repair.",
keywords = "Aggrecan, Biomimetics, Cartilage, Extracellular matrix, Proteolytic enzymes",
author = "Shaili Sharma and Aeju Lee and Kuiwon Choi and Kwangmeyung Kim and Inchan Youn and Stephen Trippel and Alyssa Panitch",
year = "2013",
month = "9",
doi = "10.1002/mabi.201300112",
language = "English",
volume = "13",
pages = "1228--1237",
journal = "Macromolecular Bioscience",
issn = "1616-5187",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models

AU - Sharma, Shaili

AU - Lee, Aeju

AU - Choi, Kuiwon

AU - Kim, Kwangmeyung

AU - Youn, Inchan

AU - Trippel, Stephen

AU - Panitch, Alyssa

PY - 2013/9

Y1 - 2013/9

N2 - Aggrecan, a major macromolecule in cartilage, protects the extracellular matrix (ECM) from degradation during the progression of osteoarthritis (OA). However, aggrecan itself is also susceptible to proteolytic cleavage. Here, the use of a biomimetic proteoglycan (mAGC) is presented, which functionally mimics aggrecan but lacks the known cleavage sites, protecting the molecule from proteolytic degradation. The objective of this study is to test the efficacy of this molecule in ex vivo (human OA synovial fluid) and in vivo (Sprague-Dawley rats) osteoarthritic models. These results indicate that mAGC's may protect articular cartilage against the loss of key ECM components, and lower catabolic protein and gene expression in both models. This suppression of matrix degradation has the potential to provide a healthy environment for tissue repair.

AB - Aggrecan, a major macromolecule in cartilage, protects the extracellular matrix (ECM) from degradation during the progression of osteoarthritis (OA). However, aggrecan itself is also susceptible to proteolytic cleavage. Here, the use of a biomimetic proteoglycan (mAGC) is presented, which functionally mimics aggrecan but lacks the known cleavage sites, protecting the molecule from proteolytic degradation. The objective of this study is to test the efficacy of this molecule in ex vivo (human OA synovial fluid) and in vivo (Sprague-Dawley rats) osteoarthritic models. These results indicate that mAGC's may protect articular cartilage against the loss of key ECM components, and lower catabolic protein and gene expression in both models. This suppression of matrix degradation has the potential to provide a healthy environment for tissue repair.

KW - Aggrecan

KW - Biomimetics

KW - Cartilage

KW - Extracellular matrix

KW - Proteolytic enzymes

UR - http://www.scopus.com/inward/record.url?scp=84884819295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884819295&partnerID=8YFLogxK

U2 - 10.1002/mabi.201300112

DO - 10.1002/mabi.201300112

M3 - Article

C2 - 23836445

AN - SCOPUS:84884819295

VL - 13

SP - 1228

EP - 1237

JO - Macromolecular Bioscience

JF - Macromolecular Bioscience

SN - 1616-5187

IS - 9

ER -